Deficiency of presenilin-1 inhibits the normal cleavage of amyloid precursor protein
The DOI matches its Crossref record; 30 of the 30 references it cites were found in a registry or an index.
Abstract
Point mutations in the presenilin-1 gene (PS1) are a major cause of familial Alzheimer's disease. They result in a selective increase in the production of the amyloidogenic peptide amyloid-beta(1-42) by proteolytic processing of the amyloid precursor protein (APP). Here we investigate whether PS1 is also involved in normal APP processing in neuronal cultures derived from PS1-deficient mouse embryos. Cleavage by alpha- and beta-secretase of the extracellular domain of APP was not affected by the absence of PS1, whereas cleavage by gamma-secretase of the transmembrane domain of APP was prevented, causing carboxyl-terminal fragments of APP to accumulate and a fivefold drop in the production of amyloid peptide. Pulse-chase experiments indicated that PS1 deficiency specifically decreased the turnover of the membrane-associated fragments of APP. As in the regulation of cholesterol metabolism by proteolysis of a membrane-bound transcription factor, PS1 appears to facilitate a proteolytic activity that cleaves the integral membrane domain of APP. Our results indicate that mutations in PS1 that manifest clinically cause a gain of function and that inhibition of PS1 activity is a potential target for anti-amyloidogenic therapy in Alzheimer's disease.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Aβ is produced by sequential β- and γ-secretase proteolytic cleavage of the amyloid precursor protein (APP) [11–17].”
From Amyloid-β interrupts canonical Sonic hedgehog signaling by distorting primary cilia structure (2018) · cites this paper as [13]
In the citing paper
“The three major APOE variants, APOE2, APOE3, and APOE4, differ from each other at two amino acid positions, 112 and 158, and modulate AD risk. E3 is the most common APOE variant and is considered neutral with regards to AD risk, while E4 alleles elevate AD risk and E2 reduces AD risk12,13.”
From APOE3 - R136S mutation confers resilience against tau pathology via cGAS-STING-IFN inhibition (2024) · cites this paper as [12]
In the citing paper
“knocking out the gene results in decreased production of both βA4(1-40) and (1-42) amyloid peptides (De Strooper et al. 1998).”
From Presenilin 1 Controls γ-Secretase Processing of Amyloid Precursor Protein in Pre-Golgi Compartments of Hippocampal Neurons (1999) · cites this paper as De Strooper et al. 1998
In the citing paper
“Mutations of presenilin 1 (PS1) causing Alzheimer's disease selectively increase the secretion of the amyloidogenic βA4(1-42)”
From Presenilin 1 Controls γ-Secretase Processing of Amyloid Precursor Protein in Pre-Golgi Compartments of Hippocampal Neurons (1999) · cites this paper as De Strooper et al. 1998
In the citing paper
“As β- (and α-) clipping was virtually normal in neurons derived from those animals, the effect on APP processing is confined to γ-secretase activities (De Strooper et al. 1998).”
From Presenilin 1 Controls γ-Secretase Processing of Amyloid Precursor Protein in Pre-Golgi Compartments of Hippocampal Neurons (1999) · cites this paper as De Strooper et al. 1998
5 more claims about this paper
Create a free account to see every claim other papers make about this one.
Citations
Cites
Cloning of a gene bearing missense mutations in early-onset familial Alzheimer's disease
Sherrington, R., Rogaev, E. I., Liang, Y., Rogaeva, E. A., Levesque, G., Ikeda, M., Chi, H., Lin, C., Li, G., Holman, K., et al. (1995) · Nature · doi:10.1038/375754a0 · Cited by 4,051
Brown, M. S., & Goldstein, J. L. (1997) · Cell · doi:10.1016/s0092-8674(00)80213-5 · Cited by 3,834 · cited 1×
“As in the regulation of cholesterol metabolism by proteolysis of a membrane-bound transcription facto”
BackgroundScheuner, D., Eckman, C., Jensen, M., Song, X., Citron, M., Suzuki, N., Bird, T. D., Hardy, J., Hutton, M., Kukull, W., et al. (1996) · Nature Medicine · doi:10.1038/nm0896-864 · Cited by 2,599
Amyloid β-peptide is produced by cultured cells during normal metabolism
Haass, C., Schlossmacher, M. G., Hung, A. Y., Vigo-Pelfrey, C., Mellon, A., Ostaszewski, B. L., Lieberburg, I., Koo, E. H., Schenk, D., Teplow, D. B., et al. (1992) · Nature · doi:10.1038/359322a0 · Cited by 1,921 · cited 1×
“This was confirmed using antibodies against amino-acid residues 595–612 (R1736”
MethodAmyloid, the presenilins and Alzheimer’s disease
Hardy, J. (1997) · Trends in Neurosciences · doi:10.1016/s0166-2236(96)01030-2 · Cited by 1,370
Citron, M., Westaway, D., Xia, W., Carlson, G., Diehl, T., Levesque, G., Johnson-wood, K., Lee, M., Seubert, P., Davis, A., et al. (1997) · Nature Medicine · doi:10.1038/nm0197-67 · Cited by 1,271
Skeletal and CNS Defects in Presenilin-1-Deficient Mice
Shen, J., Bronson, R. T., Chen, D. F., Xia, W., Selkoe, D. J., & Tonegawa, S. (1997) · Cell · doi:10.1016/s0092-8674(00)80244-5 · Cited by 959
Presenilin 1 is required for Notch 1 and Dll1 expression in the paraxial mesoderm
Wong, P. C., Zheng, H., Chen, H., Becher, M. W., Sirinathsinghji, D. J. S., Trumbauer, M. E., Chen, H. Y., Price, D. L., Van der Ploeg, L. H. T., & Sisodia, S. S. (1997) · Nature · doi:10.1038/387288a0 · Cited by 711
Distinct sites of intracellular production for Alzheimer's disease Aβ40/42 amyloid peptides
Hartmann, T., Bieger, S. C., Brühl, B., Tienari, P. J., Ida, N., Allsop, D., Roberts, G. W., Masters, C. L., Dotti, C. G., Unsicker, K., et al. (1997) · Nature Medicine · doi:10.1038/nm0997-1016 · Cited by 709
Cellular processing of β-amyloid precursor protein and the genesis of amyloid β-peptide
Haass, C., & Selkoe, D. J. (1993) · Cell · doi:10.1016/0092-8674(93)90312-e · Cited by 686
Cited by
Items 401–500 of 1,008
Amyloid β oligomerization is induced by brain lipid rafts
Kim, S., Yi, J., & Ko, Y. (2006) · Journal of Cellular Biochemistry · doi:10.1002/jcb.20978 · Cited by 118
“Ab is generated from the APP via the activity of two proteases, b- and g-secretases [De Strooper et al., 1998; Vassar et al., 1999].”
BackgroundKim, C., Nam, D. W., Park, S. Y., Song, H., Hong, H. S., Boo, J. H., Jung, E. S., Kim, Y., Baek, J. Y., Kim, K. S., et al. (2013) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2012.03.001 · Cited by 121
Are N- and C-terminally truncated Aβ species key pathological triggers in Alzheimer's disease?
Dunys, J., Valverde, A., & Checler, F. (2018) · Journal of Biological Chemistry · doi:10.1074/jbc.r118.003999 · Cited by 114
“However, an important aspect concerned the fact that, unlike the case for canonical A species (45), A (2– 42) production remains poorly affected by presenilin-1 deficiency in neurons (44), although -secretase cleavage is obviously necessary for releasing this fragment.”
BackgroundPérez, M., Cuadros, R., Smith, M. A., Perry, G., & Avila, J. (2000) · FEBS Letters · doi:10.1016/s0014-5793(00)02323-1 · Cited by 116
Regulated Intramembrane Proteolysis of the Interleukin-1 Receptor II by α-, β-, and γ-Secretase
Kuhn, P.-H., Marjaux, E., Imhof, A., De Strooper, B., Haass, C., & Lichtenthaler, S. F. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m700356200 · Cited by 120
High Resolution Structural Characterization of Aβ42 Amyloid Fibrils by Magic Angle Spinning NMR
Colvin, M. T., Silvers, R., Frohm, B., Su, Y., Linse, S. S., & Griffin, R. G. (2015) · Journal of the American Chemical Society · doi:10.1021/jacs.5b03997 · Cited by 120
Wolfe, M. S. (2009) · Chemical Reviews · doi:10.1021/cr8004197 · Cited by 134
Learning by Failing: Ideas and Concepts to Tackle γ-Secretases in Alzheimer's Disease and Beyond
De Strooper, B., & Chávez Gutiérrez, L. (2015) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev-pharmtox-010814-124309 · Cited by 119
Silvestri, R. (2009) · Medicinal Research Reviews · doi:10.1002/med.20132 · Cited by 119
Alternative splicing of mRNA in the molecular pathology of neurodegenerative diseases
Mills, J. D., & Janitz, M. (2011) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2011.10.030 · Cited by 136
PSENEN and NCSTN Mutations in Familial Hidradenitis Suppurativa (Acne Inversa)
Pink, A., Simpson, M. A., Brice, G. W., Smith, C. H., Desai, N., Mortimer, P. S., Barker, J. N. W. N., & Trembath, R. C. (2011) · Journal of Investigative Dermatology · doi:10.1038/jid.2011.42 · Cited by 126
Alzheimer's disease: β‐Amyloid protein and tau
Morishima‐Kawashima, M., & Ihara, Y. (2002) · Journal of Neuroscience Research · doi:10.1002/jnr.10355 · Cited by 116
“The cells from PS1deficient mice (De Strooper et al., 1998) and the cells from PS1 and PS2 doubly deficient mice (Herreman et al., 2000; Zhang et al., 2000) show markedly reduced and almost undetectable A production, respectively, which accompanies a remarkable accumulation of APP CTFs, C83 and…”
BackgroundRegulated ADAM10-dependent Ectodomain Shedding of γ-Protocadherin C3 Modulates Cell-Cell Adhesion
Reiss, K., Maretzky, T., Haas, I. G., Schulte, M., Ludwig, A., Frank, M., & Saftig, P. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m602663200 · Cited by 112
Epigenetics: A novel therapeutic approach for the treatment of Alzheimer's disease
Adwan, L., & Zawia, N. H. (2013) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2013.03.010 · Cited by 115
“In addition, neurons lacking the PS1 gene fail to produce Aβ peptides (De Strooper et al., 1998; Naruse et al., 1998).”
Physiological Functions of the β-Site Amyloid Precursor Protein Cleaving Enzyme 1 and 2
Yan, R. (2017) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2017.00097 · Cited by 106
“…Sinha et al., 1999; Vassar et al., 1999; Yan et al., 1999), while the γ-secretase consists of presenilin-1 or -2, which forms a complex with additional multi-TM proteins nicastrin, pen2, and Aph1 (De Strooper et al., 1998; Wolfe et al., 1999; Li et al., 2000; Yu et al., 2000; Francis et al., 2002).”
BackgroundSaunders, A. J., Kim, T.-W., & Tanzi, R. E. (1999) · Science · doi:10.1126/science.286.5443.1255a · Cited by 117
Berezovska, O., Jack, C., McLean, P., Aster, J. C., Hicks, C., Xia, W., Wolfe, M. S., Kimberly, W. T., Weinmaster, G., Selkoe, D. J., et al. (2000) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2000.0750583.x · Cited by 119
Petit, D., Fernández, S. G., Zoltowska, K. M., Enzlein, T., Ryan, N. S., O’Connor, A., Szaruga, M., Hill, E., Vandenberghe, R., Fox, N. C., et al. (2022) · Molecular Psychiatry · doi:10.1038/s41380-022-01518-6 · Cited by 120
GSK3β Activity Modifies the Localization and Function of Presenilin 1
Uemura, K., Kuzuya, A., Shimozono, Y., Aoyagi, N., Ando, K., Shimohama, S., & Kinoshita, A. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m610708200 · Cited by 115
Alzheimer's Disease Mechanisms and Emerging Roads to Novel Therapeutics
Sala Frigerio, C., & De Strooper, B. (2016) · Annual Review of Neuroscience · doi:10.1146/annurev-neuro-070815-014015 · Cited by 116
“Aβ and the proteases generating it (De Strooper et al. 1998, Vassar et al. 1999) AMYLOID CASCADE HYPOTHESIS FOR AD The amyloid cascade hypothesis posits that Aβ aggregation is the starting point of a series of events ultimately leading to AD.”
Abelein, A., Abrahams, J. P., Danielsson, J., Gräslund, A., Jarvet, J., Luo, J., Tiiman, A., & Wärmländer, S. K. T. S. (2014) · JBIC Journal of Biological Inorganic Chemistry · doi:10.1007/s00775-014-1131-8 · Cited by 122
Kimberly, W. T., LaVoie, M. J., Ostaszewski, B. L., Ye, W., Wolfe, M. S., & Selkoe, D. J. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m204446200 · Cited by 113
Synaptic Dysfunction in Alzheimer’s Disease
Marcello, E. E., Epis, R., Saraceno, C., & Luca, M. D. (2012) · Advances in experimental medicine and biology · doi:10.1007/978-3-7091-0932-8_25 · Cited by 125
Familial Alzheimer’s Disease Mutations in Presenilin Generate Amyloidogenic Aβ Peptide Seeds
Veugelen, S., Saito, T., Saido, T. C., Chávez‐Gutiérrez, L., & Strooper, B. D. (2016) · Neuron · doi:10.1016/j.neuron.2016.03.010 · Cited by 130
Intracellular pathways underlying the effects of lithium
Pasquali, L., Busceti, C. L., Fulceri, F., Paparelli, A., & Fornai, F. (2010) · Behavioural Pharmacology · doi:10.1097/fbp.0b013e32833da5da · Cited by 112
“Abeta peptides derive from the amyloid precursor protein (APP) by sequential proteolysis, catalyzed by the aspartyl protease BACE2, followed by presenilin-dependent gsecretase cleavage (De Strooper et al., 1998).”
BackgroundPresenilin-dependent regulated intramembrane proteolysis and γ-secretase activity
McCarthy, J. V., Twomey, C., & Wujek, P. (2009) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-009-8435-9 · Cited by 139
Presenilin-1 uses phospholipase D1 as a negative regulator of β-amyloid formation
Cai, D., Netzer, W. J., Zhong, M., Lin, Y., Du, G., Frohman, M., Foster, D. A., Sisodia, S. S., Xu, H., Gorelick, F. S., et al. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0510708103 · Cited by 111
Maesako, M., Uemura, K., Kubota, M., Kuzuya, A., Sasaki, K., Asada, M., Watanabe, K., Hayashida, N., Ihara, M., Ito, H., et al. (2011) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2011.10.028 · Cited by 129
“Presenilin 1 and Presenilin 2 (PS1 and PS2) are known to be the catalytic core of γ-secretase (De Strooper et al. 1998).”
BackgroundInflammatory pathogenesis in Alzheimer's disease: biological mechanisms and cognitive sequeli
Gahtan, E., & Overmier, J. B. (1999) · Neuroscience & Biobehavioral Reviews · doi:10.1016/s0149-7634(98)00058-x · Cited by 121
Tay, W. M., Huang, D., Rosenberry, T. L., & Paravastu, A. K. (2013) · Journal of Molecular Biology · doi:10.1016/j.jmb.2013.04.003 · Cited by 121
“NMR analyses, no structural differences between samples of Iβ and Aβ(1-40) fibrils were detected.”
BackgroundMethodInfluentialThe Role of Adams in Notch Signaling
Groot, A. J., & Vooijs, M. (2012) · Advances in experimental medicine and biology · doi:10.1007/978-1-4614-0899-4_2 · Cited by 123
Oxidative Stress in Alzheimer’s Disease: Should We Keep Trying Antioxidant Therapies?
Ferreira, M. E. S., de Vasconcelos, A. S., Vilhena, T. D. C., da Silva, T. L., Barbosa, A. D. S., Gomes, A. R. Q., Dolabela, M. F., & Percário, S. (2015) · Cellular and Molecular Neurobiology · doi:10.1007/s10571-015-0157-y · Cited by 118
“Mutations in bAPP genes and PS genes promote bA formation, especially bA42 (De Strooper et al. 1998; Behl 1999).”
BackgroundRegulated Intramembrane Proteolysis: Signaling Pathways and Biological Functions
Lal, M., & Caplan, M. (2011) · Physiology · doi:10.1152/physiol.00028.2010 · Cited by 101
“Accumulation of extracellular amyloid peptide is considered the central cause of neuron degeneration in Alzheimer’s disease (12).”
BackgroundBaulac, S., LaVoie, M. J., Kimberly, W. T., Strahle, J., Wolfe, M. S., Selkoe, D. J., & Xia, W. (2003) · Neurobiology of Disease · doi:10.1016/s0969-9961(03)00123-2 · Cited by 91
Characterization of α2,6-Sialyltransferase Cleavage by Alzheimer's β-Secretase (BACE1)
Kitazume, S., Tachida, Y., Oka, R., Kotani, N., Ogawa, K., Suzuki, M., Dohmae, N., Takio, K., Saido, T. C., & Hashimoto, Y. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m206262200 · Cited by 109
Amyloid precursor protein is trafficked and secreted via synaptic vesicles
Groemer, T. W., Thiel, C. S., Holt, M., Riedel, D., Hua, Y., Hüve, J., Wilhelm, B. G., & Klingauf, J. (2011) · PLoS ONE · doi:10.1371/journal.pone.0018754 · Cited by 96
“– the so-called ‘amylogenic pathway’ [4].”
Nyabi, O., Bentahir, M., Horré, K., Herreman, A., Gottardi-Littell, N., Van Broeckhoven, C., Merchiers, P., Spittaels, K., Annaert, W., & De Strooper, B. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m306957200 · Cited by 110
Self-citationA critical analysis of the ‘amyloid cascade hypothesis’
A. Armstrong, R. (2014) · Folia Neuropathologica · doi:10.5114/fn.2014.45562 · Cited by 110
“Alternatively, deficiency of PSEN1 may inhibit the normal cleavage of APP [34,141].”
BackgroundPharmacogenomics in Alzheimer's Disease
Cacabelos, R. (2008) · Methods in Molecular Biology™ · doi:10.1007/978-1-59745-205-2_10 · Cited by 109
Chávez-Gutiérrez, L., Tolia, A., Maes, E., Li, T., Wong, P. C., & de Strooper, B. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m803040200 · Cited by 105
Herms, J., Schneider, I., Dewachter, I., Caluwaerts, N., Kretzschmar, H., & Van Leuven, F. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m206769200 · Cited by 108
Pigino, G., Pelsman, A., Mori, H., & Busciglio, J. (2001) · The Journal of Neuroscience · doi:10.1523/jneurosci.21-03-00834.2001 · Cited by 111
“Recent experiments suggest that PS1 is g-secretase (Li et al., 2000) and that its function is related to the trafficking, turnover, and cleavage of amyloid precursor protein (APP; De Strooper et al., 1998; Wolfe et al., 1999) and other membrane proteins.”
BackgroundPresenilin 2 Interacts with Sorcin, a Modulator of the Ryanodine Receptor
Pack-Chung, E., Meyers, M. B., Pettingell, W. P., Moir, R. D., Brownawell, A. M., Cheng, I., Tanzi, R. E., & Kim, T.-W. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m909882199 · Cited by 110
Dewachter, I., Van Dorpe, J., Smeijers, L., Gilis, M., Kuipéri, C., Laenen, I., Caluwaerts, N., Moechars, D., Checler, F., Vanderstichele, H., et al. (2000) · The Journal of Neuroscience · doi:10.1523/jneurosci.20-17-06452.2000 · Cited by 105
“Because g-secretase is controlled by or identical to PS1 (De Strooper et al., 1998; Wolfe et al., 1999; Kimberly et al., 2000; Li et al., 2000; Selkoe and Wolfe, 2000), we have comparatively analyzed Received May 31, 2000; accepted June 16, 2000.”
BackgroundMethodSelf-citationWilson, C. A., Murphy, D. D., Giasson, B. I., Zhang, B., Trojanowski, J. Q., & Lee, V. M.-Y. (2004) · The Journal of Cell Biology · doi:10.1083/jcb.200403061 · Cited by 106
“PS1 was initially shown to play a role in the intramembrane cleavage of the amyloid precursor protein (APP; De Strooper et al., 1998) and Notch (De Strooper et al., 1999) and was subsequently documented to cleave additionally a growing list of type I transmembrane proteins including Erb-b4,…”
BackgroundMizutani, T., Taniguchi, Y., Aoki, T., Hashimoto, N., & Honjo, T. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.161269998 · Cited by 108
Berezovska, O., Ramdya, P., Skoch, J., Wolfe, M. S., Bacskai, B. J., & Hyman, B. T. (2003) · The Journal of Neuroscience · doi:10.1523/jneurosci.23-11-04560.2003 · Cited by 108
“It is now recognized that presenilin 1 (PS1), a gene known to cause early-onset autosomal dominant Alzheimer’s disease, is critical for the -secretase activity (De Strooper et al., 1998).”
BackgroundA Role for P-Glycoprotein in Clearance of Alzheimer Amyloid ? -Peptide from the Brain
Wang, W., M. Bodles-Brakhop, A., & W. Barger, S. (2016) · Current Alzheimer Research · doi:10.2174/1567205013666160314151012 · Cited by 107
“Aβ is the proteolytic product of β-amyloid precursor protein (APP) after sequential cleavages by β- and γsecretases (2).”
BackgroundBACE (β-secretase) modulates the processing of APLP2 in vivo
Pastorino, L., Ikin, A. F., Lamprianou, S., Vacaresse, N., Revelli, J. P., Platt, K., Paganetti, P., Mathews, P. M., Harroch, S., & Buxbaum, J. D. (2004) · Molecular and Cellular Neuroscience · doi:10.1016/j.mcn.2003.12.013 · Cited by 84
Tomita, T., Takikawa, R., Koyama, A., Morohashi, Y., Takasugi, N., Saido, T. C., Maruyama, K., & Iwatsubo, T. (1999) · The Journal of Neuroscience · doi:10.1523/jneurosci.19-24-10627.1999 · Cited by 106
“The finding that ablation of PS1 in mice dramatically decreased g-cleavage of bAPP indicated that PS1 physiologically serves as a coactivator of g-secretase (De Strooper et al., 1998).”
BackgroundSchulz, J. G., Annaert, W., Vandekerckhove, J., Zimmermann, P., De Strooper, B., & David, G. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m308424200 · Cited by 104
Self-citationCell‐free assays for γ‐secretase activity
McLendon, C., Xin, T., Ziani-Cherif, C., Murphy, M. P., Findlay, K. A., Lewis, P. A., Pinnix, I., Sambamurti, K., Wang, R., Fauq, A., et al. (2000) · The FASEB Journal · doi:10.1096/fj.00-0286fje · Cited by 107
Evin, G. M., Sernee, M. F., & Masters, C. L. (2006) · CNS Drugs · doi:10.2165/00023210-200620050-00002 · Cited by 119
Presenilin-dependent “γ-Secretase” Processing of Deleted in Colorectal Cancer (DCC)
Taniguchi, Y., Kim, S.-H., & Sisodia, S. S. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.c300239200 · Cited by 99
Chen, F., Gu, Y., Hasegawa, H., Ruan, X., Arawaka, S., Fraser, P., Westaway, D., Mount, H., & St George-Hyslop, P. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m205093200 · Cited by 106
Levesque, G., Yu, G., Nishimura, M., Zhang, D. M., Levesque, L., Yu, H., Xu, D., Liang, Y., Rogaeva, E., Ikeda, M., et al. (1999) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1999.0720999.x · Cited by 107
“…differentiation (Levitan and Greenwald, 1995; Shen et al., 1997; Wong et al., 1997), in apoptotic signal transduction (Deng et al., 1996; Vito et al., 1996; Wolozin et al., 1996), and in the regulation of proteolytic cleavage of theb-amyloid precursor protein (bAPP) (De Strooper et al., 1998).”
Calpain Activity Regulates the Cell Surface Distribution of Amyloid Precursor Protein
Mathews, P. M., Jiang, Y., Schmidt, S. D., Grbovic, O. M., Mercken, M., & Nixon, R. A. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m205208200 · Cited by 104
Specific Compositions of Amyloid-β Peptides as the Determinant of Toxic β-Aggregation
Yoshiike, Y., Chui, D.-H., Akagi, T., Tanaka, N., & Takashima, A. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m212785200 · Cited by 102
Presenilins are required for the formation of comma- and S-shaped bodies during nephrogenesis
Wang, P., Pereira, F. A., Beasley, D., & Zheng, H. (2003) · Development · doi:10.1242/dev.00682 · Cited by 113
“…transmembrane proteins that are essential to process the β-amyloid precursor protein (APP) at the γ-secretase site to generate Aβ40 and Aβ42, peptides that constitute major components of the βamyloid plaques characteristic of Alzheimer’s disease (AD) (De Strooper et al., 1998; Selkoe, 1998).”
Structural basis of human γ-secretase assembly
Sun, L., Zhao, L., Yang, G., Yan, C., Zhou, R., Zhou, X., Xie, T., Zhao, Y., Wu, S., Li, X., et al. (2015) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1506242112 · Cited by 102
“Amyloid precursor protein (APP) is processed by β-secretase in the extracellular space to produce a membrane-tethered fragment known as C99 (3).”
BackgroundInfluentialStepping closer to treating Alzheimer’s disease patients with BACE1 inhibitor drugs
Yan, R. (2016) · Translational Neurodegeneration · doi:10.1186/s40035-016-0061-5 · Cited by 100
“A membrane-bound aspartyl protease called BACE1 was discovered as the β-secretase [41, 54, 71, 88, 92], while the γ-secretase is a complex consisting of four transmembrane proteins: presenilin-1 or −2, nicastrin, Aph1, and Pen2 [11, 20, 52, 53, 100].”
BackgroundMori, T., Koyama, N., Tan, J., Segawa, T., Maeda, M., & Town, T. (2018) · Journal of Biological Chemistry · doi:10.1074/jbc.ra118.004280 · Cited by 106
Wu, H., Chen, S., Al-Baadani, A., Xu, J., Wu, Q., Pan, K., Zhang, J., & Hong, Y. (2014) · Molecular Neurobiology · doi:10.1007/s12035-014-8933-0 · Cited by 107
“Missense mutations in the amyloid precursor protein (APP) and presenilin genes can lead to an increase in the production of the amyloid-beta (Aβ) peptide, which can predispose to the development of AD-type brain pathology [65–69].”
BackgroundLi, H., Liu, C.-C., Zheng, H., & Huang, T. Y. (2018) · Translational Neurodegeneration · doi:10.1186/s40035-018-0139-3 · Cited by 103
The amyloid‐β peptide and its role in Alzheimer's disease
Clippingdale, A. B., Wade, J. D., & Barrow, C. J. (2001) · Journal of Peptide Science · doi:10.1002/psc.324 · Cited by 97
Presenilin structure, function and role in Alzheimer disease
Fraser, P. E., Yang, D.-S., Yu, G., Lévesque, L., Nishimura, M., Arawaka, S., Serpell, L. C., Rogaeva, E. A., & George‐Hyslop, P. S. (2000) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/s0925-4439(00)00028-4 · Cited by 118
Notch and Presenilin: a proteolytic mechanism emerges
Fortini, M. (2001) · Current Opinion in Cell Biology · doi:10.1016/s0955-0674(00)00261-1 · Cited by 115
Secretion of the Notch-1 Aβ-like Peptide during Notch Signaling
Okochi, M., Fukumori, A., Jiang, J., Itoh, N., Kimura, R., Steiner, H., Haass, C., Tagami, S., & Takeda, M. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m513250200 · Cited by 100
Identity and function of γ‐secretase
Kimberly, W. T., & Wolfe, M. S. (2003) · Journal of Neuroscience Research · doi:10.1002/jnr.10736 · Cited by 102
“The deficiency of PS1 in knockout mouse neurons resulted in sharply reduced A production and a concomitant accumulation of the 83- and 99-amino acid APP C-terminal -secretase substrates, C83 and C99 (De Strooper et al., 1998).”
BackgroundWinton, M. J., Lee, E. B., Sun, E., Wong, M. M., Leight, S., Zhang, B., Trojanowski, J. Q., & Lee, V. M.-Y. (2011) · The Journal of Neuroscience · doi:10.1523/jneurosci.6637-10.2011 · Cited by 100
RetractedMoin, S. M., & Urban, S. (2012) · eLife · doi:10.7554/elife.00173 · Cited by 98
“…the membrane, including the intracellular domains of the Notch receptor and the amyloid-β precursor protein (APP) implicated in Alzheimer’s disease (De Strooper et al., 1998, 1999; *For correspondence: surban@ jhmi.edu †Present address: Vaccine Research Center, National Institute of Allergy and…”
BackgroundStructure and function of γ-secretase
Tolia, A., & Strooper, B. D. (2008) · Seminars in Cell and Developmental Biology · doi:10.1016/j.semcdb.2008.10.007 · Cited by 113
Glycogen Synthase Kinase-3β Regulates Presenilin 1 C-terminal Fragment Levels
Kirschenbaum, F., Hsu, S.-C., Cordell, B., & McCarthy, J. V. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m102849200 · Cited by 100
Presenilins are not required for Aβ42 production in the early secretory pathway
Wilson, C., Doms, R. W., Zheng, H., & Lee, V. M. ‐. (2002) · Nature Neuroscience · doi:10.1038/nn898 · Cited by 111
“Alzheimer’s Aβ (1-42) is generated in the endoplasmic reticulum/intermediate compartment of NT2N cells.”
Marginal vitamin A deficiency facilitates Alzheimer’s pathogenesis
Zeng, J., Chen, L., Wang, Z., Chen, Q., Fan, Z., Jiang, H., Wu, Y., Ren, L., Chen, J., Li, T., et al. (2017) · Acta Neuropathologica · doi:10.1007/s00401-017-1669-y · Cited by 105
“Moreover, PSEN1 is the catalytic subunit of γ-secretase complex and its dysregulation contributes to the dysregulation of Aβ generation, promoting AD pathogenesis [13, 71].”
BackgroundPresenilins interact with Rab11, a small GTPase involved in the regulation of vesicular transport
Dumanchin, C. (1999) · Human Molecular Genetics · doi:10.1093/hmg/8.7.1263 · Cited by 99
“In neuronal cells deri from PS1–/PS1– mouse embryos, there is an inhibition of AP cleavage byγ-secretase (30).”
Backgroundp53 in neurodegenerative diseases and brain cancers
Checler, F., & da Costa, C. A. (2013) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2013.11.009 · Cited by 104
“The latter catabolite undergoes an additional C-terminal truncation by both presenilin-dependent (De Strooper et al., 1998) and independent (Armogida et al., 2001) γ-secretases that ultimately liberate “full length” Aβ (flAβ) species (Lefranc-Jullien, Sunyach, & Checler, 2006).”
Modulation of Disordered Proteins with a Focus on Neurodegenerative Diseases and Other Pathologies
Martinelli, A. H. S., Lopes, F. C., John, E. B. D. O., Carlini, C. R., & Ligabue‐Braun, R. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20061322 · Cited by 105
Famer, D., Meaney, S., Mousavi, M. T., Nordberg, A. K., Björkhem, I., & Crisby, M. (2007) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2007.05.033 · Cited by 105
Arduengo, P. M., Appleberry, O. K., Chuang, P., & L’Hernault, S. W. (1998) · Journal of Cell Science · doi:10.1242/jcs.111.24.3645 · Cited by 98
The JNK/c-Jun cascade and Alzheimer's disease
Okazawa, H., & Estus, S. (2002) · American Journal of Alzheimer s Disease & Other Dementias® · doi:10.1177/153331750201700209 · Cited by 104
Biological function of Presenilin and its role in AD pathogenesis
Zhang, S., Zhang, M., Cai, F., & Song, W. (2013) · Translational Neurodegeneration · doi:10.1186/2047-9158-2-15 · Cited by 91
“PS1 knockout mice showed markedly reduced γ-secretase cleavage of APP [38] and knockout of both PS1 and PS2 completely abolished γ-secretase activity [40,68].”
BackgroundPresenilins and Alzheimer's disease
Kim, T.-W., & Tanzi, R. E. (1997) · Current Opinion in Neurobiology · doi:10.1016/s0959-4388(97)80089-x · Cited by 97
Proteolytic Cleavage of Notch: “HIT and RUN”
van Tetering, G., & Vooijs, M. (2011) · Current Molecular Medicine · doi:10.2174/156652411795677972 · Cited by 115
“Deficiency of PS1/2 inhibits the normal cleavage of APP, Notch and other RIP substrates indicating its key importance for γ-secretase activity [126, 127].”
BackgroundTabuchi, K., Chen, G., Südhof, T. C., & Shen, J. (2009) · The Journal of Neuroscience · doi:10.1523/jneurosci.1320-09.2009 · Cited by 98
“…subunit, presenilin possesses -secretase independent activities, such as the regulation of Ca 2 release from the endoplasmic reticulum (De Strooper et al., 1998, 1999; Kang et al., 1999, 2002; Ni et al., 2001; Kim et al., 2002, 2005; LaFerla, 2002; Lammich et al., 2002; Lee et al., 2002;…”
BackgroundNadler, Y., Alexandrovich, A., Grigoriadis, N., Hartmann, T., Rao, K. S. J., Shohami, E., & Stein, R. (2008) · Glia · doi:10.1002/glia.20638 · Cited by 92
“Among the substrates of g-secretase are amyloid precursor protein (APP) (De Strooper et al., 1998), Notch (Selkoe and Kopan, 2003), ErbB4 (Ni et al., 2001), CD44 (Murakami et al., 2003), and E-cadherin (Marambaud et al., 2002).”
BackgroundTalking Point on the role of presenilin mutations in Alzheimer disease
Strooper, B. D. (2007) · Cited by 97
Presenilins function in ER calcium leak and Alzheimer's disease pathogenesis
Supnet, C., & Bezprozvanny, I. (2011) · Cell Calcium · doi:10.1016/j.ceca.2011.05.013 · Cited by 95
“…PS-FAD mutations result in a shift in the proteolysis of APP such that there is an increase in the production the hydrophobic, aggregation-prone 1–42 Aβ fragment, increasing Aβ42/40 ratio and contributing to Aβ plaque formation (De Strooper et al., 1998; Scheuner et al., 1996; Wolfe et al., 1999).”
BackgroundEmerging Link between Alzheimer’s Disease and Homeostatic Synaptic Plasticity
Jang, S.-S., & Chung, H. J. (2016) · Neural Plasticity · doi:10.1155/2016/7969272 · Cited by 89
“Aβ peptides are generated by successive proteolysis of amyloid-β precursor protein (APP), a large transmembrane glycoprotein that is initially cleaved by theβ-site APP-cleaving enzyme 1 (BACE1) and subsequently by γ-secretase in the transmembrane domain [62–64].”
BackgroundSecretases as targets for the treatment of Alzheimer's disease: the prospects
Dewachter, I., & LEUVEN, F. V. (2002) · The Lancet Neurology · doi:10.1016/s1474-4422(02)00188-6 · Cited by 103
Presenilin 1 Regulates Pharmacologically Distinct γ-Secretase Activities
Murphy, M. P., Uljon, S. N., Fraser, P. E., Fauq, A., Lookingbill, H. A., Findlay, K. A., Smith, T. E., Lewis, P. A., McLendon, D. C., Wang, R., et al. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m002812200 · Cited by 97
Endogenous β-amyloid production in presenilin-deficient embryonic mouse fibroblasts
Armogida, M., Petit-Paitel, A., Vincent, B., Scarzello, S., da Costa, C. A., & Checler, F. (2001) · Nature Cell Biology · doi:10.1038/ncb1101-1030 · Cited by 99
De Jonghe, C., MarcCruts, Rogaeva, E. A., Tysoe, C., Singleton, A., Vanderstichele, H., Meschino, W., Dermaut, B., Vanderhoeven, I., Backhovens, H., et al. (1999) · Human Molecular Genetics · doi:10.1093/hmg/8.8.1529 · Cited by 93
Self-citationVingtdeux, V., Hamdane, M., Gompel, M., Bégard, S., Drobecq, H., Ghestem, A., Grosjean, M.-E., Kostanjevecki, V., Grognet, P., Vanmechelen, E., et al. (2005) · Neurobiology of Disease · doi:10.1016/j.nbd.2005.05.004 · Cited by 88
Fukumori, A., & Steiner, H. (2016) · The EMBO Journal · doi:10.15252/embj.201694151 · Cited by 94
“Apart from the AD-associated APP (De Strooper et al , 1998; Naruse et al , 1998), c -secretase cleaves many other type I membrane protein substrates (Haapasalo & Kovacs, 2011), foremost the Notch1 receptor (De Strooper et al , 1999; Struhl & Greenwald, 1999), a crucial signaling protein, which has…”
InfluentialCopper imbalance in Alzheimer’s disease: Convergence of the chemistry and the clinic
Kepp, K. P., & Squitti, R. (2019) · Coordination Chemistry Reviews · doi:10.1016/j.ccr.2019.06.018 · Cited by 96
Differential cerebral deposition of IDE and NEP in sporadic and familial Alzheimer's disease
Dorfman, V. B., Pasquini, L., Riudavets, M., López-Costa, J. J., Villegas, A., Troncoso, J. C., Lopera, F., Castaño, E. M., & Morelli, L. (2010) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2008.09.016 · Cited by 90
Theuns, J. (2000) · Human Molecular Genetics · doi:10.1093/hmg/9.3.325 · Cited by 92
“On the other hand, in neuronal cell cultures derived from PSEN1 deficient mice, APP processing into Aβ peptides was prevented (25).”
BackgroundMartoglio, B., & Golde, T. E. (2003) · Human Molecular Genetics · doi:10.1093/hmg/ddg303 · Cited by 98
Lysosome and calcium dysregulation in Alzheimer's disease: partners in crime
McBrayer, M., & Nixon, R. A. (2013) · Biochemical Society Transactions · doi:10.1042/bst20130201 · Cited by 89
Metadata
- Authors
- De Strooper, B., Saftig, P., Craessaerts, K., Vanderstichele, H., Guhde, G., Annaert, W., Von Figura, K., & Van Leuven, F.
- Affiliations
- Vlaams Instituut voor Biotechnologie (BE)
- University of Göttingen (DE)
- Venue
- Nature
- Published
- 1998-01
- Volume
- 391
- Issue
- 6665
- Pages
- 387-390
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- OpenAlex
- W1655404681
- Cited by
- 1,818
- References
- 30
- Citations by year
- 2026: 19 · 2025: 39 · 2024: 47 · 2023: 42 · 2022: 33 · 2021: 35 · 2020: 53 · 2019: 43 · 2018: 36 · 2017: 58 · 2016: 60 · 2015: 43 · 2014: 55 · 2013: 64 · 2012: 71
- FWCI
- 76.15
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature (publishedVersion)
- PubMed (publishedVersion)
- RePEc: Research Papers in Economics (submittedVersion)
- UCL Discovery (University College London) (submittedVersion)
- Topics
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
- Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
- Life Sciences › Neuroscience › Neurology › Neuroinflammation and Neurodegeneration Mechanisms
- Keywords
- presenilin 1, amyloid precursor protein, APP processing, gamma-secretase, amyloid-beta 42, Alzheimer's disease, familial Alzheimer's disease, carboxyl-terminal fragment, gain-of-function, membrane proteolysis
- MeSH terms
- Animals, Cells, Cultured, Humans, Membrane Proteins, Neurons, Peptide Fragments, Endopeptidases, Protein Processing, Post-Translational, Amyloid beta-Peptides, Aspartic Acid Endopeptidases, Amyloid beta-Protein Precursor, Point Mutation, Mice, Presenilin-1, Amyloid Precursor Protein Secretases
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.